222 results
DEFA14A
CRDF
Cardiff Oncology Inc
25 Apr 24
Additional proxy soliciting materials
4:10pm
. We encourage you to access and review all of the important information contained in the proxy
materials before voting.
This is not a ballot. You … materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy
DEFA14A
CRDF
Cardiff Oncology Inc
27 Apr 23
Additional proxy soliciting materials
4:01pm
by e-mail or first-class mail. We encourage you to access and review all of the important information contained in the proxy materials before voting … complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained
8-K
EX-99.1
gl4nljp5g8a 6i1osh
3 Nov 22
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
4:14pm
8-K
EX-99.1
i9mi m4deyv
12 Sep 22
Regulation FD Disclosure
4:09pm
8-K
EX-99.2
bxki196 8zl
12 Sep 22
Regulation FD Disclosure
4:09pm
8-K
EX-99.01
s3inyeu gcb3b1hn
6 Sep 22
Other Events
4:07pm
DEFA14A
g9awkqv
15 Apr 22
Additional proxy soliciting materials
1:02pm
8-K
EX-99.1
23a9u1kab3a2cfp6gs4i
24 Feb 22
Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights
4:09pm
8-K
EX-99.1
85t4fify
18 Jan 22
Regulation FD Disclosure
5:00pm
424B5
594zt0l
18 Nov 21
Prospectus supplement for primary offering
10:52am
8-K
3dd ojwfy
18 Nov 21
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative
8:56am
8-K
EX-99.1
id5jfsxp
18 Nov 21
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative
8:56am